DKNG — DraftKingsFREE
Median target
$34
across the calls below
Implied return
+51.3%
median target vs. price
Coverage
38 analysts · 43 calls
within the date window
Consensus
32/6/0+32 net
Buy / Hold / Sell
Current analyst calls on DKNG
Each row is one analyst's live rating and price target. Sorted by implied return by default — click any column header to re-sort. By default only calls updated in the last 12 months are shown — change or clear the bound to see all.
43 of 55 calls shown
| Brian Pitz | – | – | – | BMO Capital | Buy | $50 | +122.5% | Mar 3, 2026 | |
| Brian Pitz | – | – | – | BMO Capital | Buy | $50 | +122.5% | May 8, 2026 | |
| Robin M. Farley | – | – | – | UBS | Buy | $49 | +118.1% | Jun 8, 2026 | |
| Steven Sheeckutz | – | – | – | Citi | Buy | $48 | +113.6% | Feb 12, 2026 | |
| Benjamin Chaiken | – | – | – | Mizuho Securities | Buy | $45 | +100.3% | May 12, 2026 | |
| David Katz | – | – | – | Jefferies | Buy | $44 | +95.8% | Aug 9, 2026 | |
| David Katz | – | – | – | Jefferies | Buy | $44 | +95.8% | Sep 4, 2026 | |
| Jason Tilchen | – | – | – | Canaccord Genuity | Buy | $44 | +95.8% | Mar 3, 2026 | |
| Matthew Weber | – | – | – | Canaccord Genuity | Buy | $44 | +95.8% | Aug 7, 2026 | |
| Arpine Kocharyan | – | – | – | UBS | Buy | $43 | +91.4% | May 8, 2026 | |
| Robin M. Farley | – | – | – | UBS | Buy | $43 | +91.4% | Mar 16, 2026 | |
| Chad Beynon | – | – | – | Macquarie | Buy | $40 | +78.0% | Feb 17, 2026 | |
| Peter Supino | – | – | – | Wolfe Research | Buy | $40 | +78.0% | Sep 2, 2026 | |
| Ed Young | – | – | – | Morgan Stanley | Buy | $39 | +73.6% | May 14, 2026 | |
| Jeffrey Stantial | – | – | – | Stifel Nicolaus | Buy | $36 | +60.2% | Aug 11, 2026 | |
| Jordan Bender | – | – | – | Citizens JMP | Buy | $36 | +60.2% | Jun 25, 2026 | |
| Stephen Grambling | – | – | – | Morgan Stanley | Buy | $36 | +60.2% | Aug 7, 2026 | |
| Stephen Grambling | – | – | – | Morgan Stanley | Buy | $36 | +60.2% | Aug 12, 2026 | |
| Bernie McTernan | – | – | – | Needham | Buy | $35 | +55.8% | Aug 7, 2026 | |
| Jed Kelly | – | – | – | Oppenheimer | Buy | $35 | +55.8% | Aug 11, 2026 | |
| Lance Vitanza | – | – | – | TD Cowen | Buy | $35 | +55.8% | Aug 11, 2026 | |
| Vamil Divan | – | – | – | Guggenheim | Buy | $35 | +55.8% | May 11, 2026 | |
| Brandt Montour | – | – | – | Barclays | Buy | $34 | +51.3% | Aug 7, 2026 | |
| Curry Baker | – | – | – | Guggenheim | Buy | $33 | +46.9% | Aug 7, 2026 | |
| Daniel Politzer | – | – | – | J.P. Morgan | Buy | $33 | +46.9% | Aug 10, 2026 | |
| James Hardiman | – | – | – | Citi | Buy | $32 | +42.4% | Aug 11, 2026 | |
| Steven Sheeckutz | – | – | – | Citi | Buy | $32 | +42.4% | Feb 17, 2026 | |
| Joseph Stauff | – | – | – | Susquehanna | Buy | $31 | +38.0% | Jul 1, 2026 | |
| Clark Lampen | – | – | – | BTIG | Buy | $30 | +33.5% | Jul 6, 2026 | |
| Mike Hickey | – | – | – | Benchmark Co. | Buy | $30 | +33.5% | Aug 31, 2026 | |
| Barry Jonas | – | – | – | Truist Financial | Buy | $29 | +29.1% | Aug 10, 2026 | |
| Ian S. Moore | – | – | – | Bernstein | Buy | $29 | +29.1% | Aug 31, 2026 | |
| Trey Bowers | – | – | – | Wells Fargo | Buy | $29 | +29.1% | Aug 25, 2026 | |
| Nick McKay | – | – | – | Freedom Capital Markets | Buy | $28.5 | +26.8% | Jul 20, 2026 | |
| Greg Gibas | – | – | – | Northland Securities | Hold | $28 | +24.6% | Aug 10, 2026 | |
| Steven Pizzella | – | – | – | Deutsche Bank | Hold | $28 | +24.6% | Jul 9, 2026 | |
| David Bain | – | – | – | Texas Capital Securities | Hold | $27 | +20.2% | Feb 18, 2026 | |
| John DeCree | – | – | – | CBRE | Buy | $27 | +20.2% | Aug 21, 2026 | |
| Shaun Kelley | – | – | – | Bank of America Securities | Hold | $27 | +20.2% | Aug 7, 2026 | |
| Jack Cummings | – | – | – | Berenberg Bank | Buy | $26.4 | +17.5% | Feb 23, 2026 | |
| John Eade | – | – | – | Argus Research | Hold | – | – | Mar 17, 2026 | |
| Robert Fishman | – | – | – | MoffettNathanson | Hold | – | – | Apr 24, 2026 | |
| Ryan Sigdahl | – | – | – | Craig-Hallum | Buy | – | – | Jun 26, 2026 |
Analyst track records are Premium — unlock every analyst's score, rank and success rate.
Implied return is the move the stock would make if the analyst's target were hit. These are forward-looking predictions, not realized returns. Only reliable-basis calls are included; the consensus figures above are computed from the calls in this table.
DKNG elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: #13 in Gaining attention (1.6× vs usual)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-08-19 | Insiders | Moore JocelynDirector | Insider sale | 10.8K sh @ $24.05 · planned trade | $259K |
| 2025-10-09 | Executive | Trump, Donald JPresident | Sale | DraftKings Inc. | $1,001 - $15,000 |
| 2025-09-08 | Executive | Trump, Donald JPresident | Sale | DraftKings Inc. | $15,001 - $500,009 |
| 2025-08-27 | Executive | Trump, Donald JPresident | Purchase | DraftKings Inc. | $15,001 - $500,008 |
| 2025-04-11 | Executive | Trump, Donald JPresident | Purchase | DraftKings Inc. | $1,001 - $150,004 |
| 2025-04-04 | Executive | Trump, Donald JPresident | Sale | DraftKings Inc. | $15,001 - $500,004 |
| 2025-03-10 | Executive | Trump, Donald JPresident | Purchase | DraftKings Inc. | $15,001 - $500,003 |
| 2025-02-11 | Executive | Duffy, SeanSecretary | Sale | DraftKings Inc. Class A Common Stock (DKNG) | $1,001 - $15,000 |
| 2025-02-11 | Executive | Duffy, SeanSecretary | Sale | DraftKings Inc. Class A Common Stock (DKNG) | $1,001 - $15,000 |
| 2021-01-21 | Congress | Marjorie Taylor GreeneGA-GA14 | Purchase | since trade -59.4%, vs market -172.3% | $1K–$15K |
More: congressional trades on DKNG · insider activity · executive branch · trending